TVARDI THERAPEUTICS, INC. Payments of Financing Costs
TVARDI THERAPEUTICS, INC. (TVRD) reported Payments of Financing Costs of $70.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2016-03-11
- TVARDI THERAPEUTICS, INC. payments of financing costs for the quarter ending 2013-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. payments of financing costs for the quarter ending 2013-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. payments of financing costs for the quarter ending 2013-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. payments of financing costs for the quarter ending 2013-03-31 was $70.00K.
- TVARDI THERAPEUTICS, INC. payments of financing costs for fiscal 2013 was $70.00K, a 48.94% increase from fiscal 2012.
- TVARDI THERAPEUTICS, INC. payments of financing costs for fiscal 2012 was $47.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | $70.00K 10-K · filed 2016-03-11 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $70.00K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $70.00K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $70.00K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $47.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |